Bicara Therapeutics Inc. (BCAX) Operating cash flow 2023–2025
Bicara Therapeutics Inc. (BCAX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$106.8MFY2025 · since FY2023: -$45.6M → -$106.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$106.8M | -42.9% |
| FY2024 | -$74.8M | -63.8% |
| FY2023 | -$45.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCAX financial trends
BCAX RevenueBCAX Net incomeBCAX Net marginBCAX Gross profitBCAX Gross marginBCAX Operating incomeBCAX Operating marginBCAX Free cash flowBCAX Capital expendituresBCAX Return on equityBCAX Stock buybacksBCAX Dividends paidBCAX Total assetsBCAX Total liabilitiesBCAX Shareholders’ equityBCAX overview →